Rapid Nutrition Announces FY2022 Results
London, United Kingdom – 2 May 2023 - Rapid Nutrition PLC (Euronext Growth: ALRPD), released its fiscal year 2022 results. A natural healthcare company focused on evidenced-based nutrition, diet management and plant-based products with growing worldwide distribution, Rapid Nutrition is dedicated to building a market-leading company with a global position in the life science and nutraceutical space.
In FY2022, Rapid Nutrition reported revenue of $2.95 million, consistent with the previous year, as well as gross profit of $2.11 million. Moreover, the company decreased its liabilities by more than 95 percent, compared to the prior year, placing the company in a strong position moving forward, despite inflationary headwinds. Rapid Nutrition also reported a 200 percent increase in cash at year-end.
“Our growth strategy remains firm, and we are pleased to report strong fundamentals, a highly experienced management team with a continued goal of imposing superior standards of quality control for all of our products,” said Rapid Nutrition CEO Simon St. Ledger. “All of this will continue to strengthen our company’s value chain and allow us to scale up to optimum business efficiency and growth.”
In 2022, Rapid Nutrition focused on generating growth in current markets by diversifying distribution channels while leveraging unique manufacturing capabilities and partnerships to optimize the supply chain with an eye towards additional growth.
About Rapid Nutrition
Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.
For more information, please visit http://rnplc.com
Investor Relations Contact:
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).